Table 1.
Clinical and demographic characteristics of the patients
| With thickness (cases) (N = 86) | Without thickness (ctrls) (N = 120) | p | |
|---|---|---|---|
| Age, years | 56.9 ± 9.6 | 55.0 ± 12.9 | 0.249 |
| M/F | 64/22 | 96/24 | 0.397 |
| Disease duration (months) | 7.8 ± 7.2 | 8.2 ± 7.3 | 0.868 |
| Familiarity | |||
| Psoriasis | 18 | 3 | <0.001 |
| Ischemic cardiopathy | 5 | 9 | 0.438 |
| Diabetes | 9 | 4 | 0.036 |
| Thyroiditis | 3 | 5 | 0.561 |
| Comorbidity | |||
| Psoriasis | 25 | 10 | <0.001 |
| Psoriatic onychopathy | 7 | 2 | 0.028 |
| Low back pain | 22 | 11 | 0.001 |
| Dupuytren’s dis. | 7 | 2 | 0.028 |
| De Quervain’s dis. | 4 | 0 | 0.028 |
| Carpal tunnel synd. | 11 | 7 | 0.065 |
| Raynaud’s phen. | 1 | 1 | 0.659 |
| Thyroiditis | 7 | 9 | 0.533 |
| Laboratory | |||
| Anemia | 8 | 12 | 0.538 |
| Thrombocytopenia | 4 | 9 | 0.029 |
| Leucopenia | 7 | 4 | 0.487 |
| ESR (mm) | 19.2 | 20.9 | 0.580 |
| CRP (mg/l) | 6.4 | 7.8 | 0.622 |
| RF | 6 | 13 | 0.258 |
| ACCP | 3 | 6 | 0.433 |
| Anti-thyroid antibodies | 3 | 5 | 0.624 |
| ANA | 12 | 21 | 0.368 |
Data presented as mean ± SD unless stated otherwise
CRP C-reactive protein assessment, ESR eritrosedimentation rate after 1 h, RF rheumatoid factor, ACCP anti-citrullinated peptides antibodies, ANA anti nuclear antibodies